Marine Andreani

Nice, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

PDL1 inhibitors may be associated with a lower risk of allograft rejection than PD1 and CTLA4 inhibitors: analysis of the WHO pharmacovigilance database.

PDL1 inhibitors may be associated with a lower risk of allograft rejection than PD1 and CTLA4 inhibitors: analysis of the WHO pharmacovigilance database.

Journal: Frontiers in immunology

Published: October 19, 2024

Whole-genome sequencing revealed a novel structural variant in COL4A4 causing autosomal dominant Alport syndrome: A case report.

Whole-genome sequencing revealed a novel structural variant in COL4A4 causing autosomal dominant Alport syndrome: A case report.

Journal: Heliyon

Published: June 11, 2024

Onco-nephrology: Physicians' Expectations About a New Subspecialty.

Onco-nephrology: Physicians' Expectations About a New Subspecialty.

Journal: Journal of cancer education : the official journal of the American Association for Cancer Education

Published: July 10, 2022

Drug-Induced Tubulointerstitial Nephritis: Insights From the World Health Organization Safety Database.

Drug-Induced Tubulointerstitial Nephritis: Insights From the World Health Organization Safety Database.

Journal: Kidney international reports

Published: March 14, 2022

Risk factors associated with immune checkpoint inhibitor-induced acute kidney injury compared with other immune-related adverse events: a case-control study.

Risk factors associated with immune checkpoint inhibitor-induced acute kidney injury compared with other immune-related adverse events: a case-control study.

Journal: Clinical kidney journal

Published: January 24, 2022

Immune checkpoint inhibitors-induced nephropathy: a French national survey.

Immune checkpoint inhibitors-induced nephropathy: a French national survey.

Journal: Cancer immunology, immunotherapy : CII

Published: February 06, 2021

Reactive angioendotheliomatosis revealing a glomerulopathy secondary to a monoclonal gammopathy successfully treated with lenalidomide.

Reactive angioendotheliomatosis revealing a glomerulopathy secondary to a monoclonal gammopathy successfully treated with lenalidomide.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: August 01, 2020

Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and Relapses.

Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and Relapses.

Journal: Frontiers in immunology

Published: June 22, 2020

Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab.

Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab.

Journal: Frontiers in immunology

Published: September 16, 2019

Monitoring of CMV-Specific Cell-Mediated Immunity in Kidney Transplant Recipients With a High Risk of CMV Disease (D+/R-): A Case Series.

Monitoring of CMV-Specific Cell-Mediated Immunity in Kidney Transplant Recipients With a High Risk of CMV Disease (D+/R-): A Case Series.

Journal: Transplantation proceedings

Published: February 11, 2019

Rituximab bioavailability in primary membranous nephropathy.

Rituximab bioavailability in primary membranous nephropathy.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: December 13, 2018

High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy.

High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: October 03, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026